Emerald Mutual Fund Advisers Trust’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-72,080
| Closed | -$5.05M | – | 229 |
|
|
2024
Q1 | $5.05M | Buy |
+72,080
| New | +$5.05M | 0.26% | 106 |
|
|
2023
Q2 | – | Sell |
-192,097
| Closed | -$6.76M | – | 255 |
|
|
2023
Q1 | $6.76M | Sell |
192,097
-178,902
| -48% | -$6.3M | 0.4% | 93 |
|
|
2022
Q4 | $17M | Buy |
370,999
+79,096
| +27% | +$3.62M | 1.05% | 38 |
|
|
2022
Q3 | $14.1M | Buy |
291,903
+165,324
| +131% | +$8.01M | 0.89% | 44 |
|
|
2022
Q2 | $4.97M | Buy |
+126,579
| New | +$4.97M | 0.29% | 103 |
|